Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001

Annals of the Rheumatic Diseases

Volumn 65, Issue 8, 2006, Pages 1093-1098

  Smeeth, Liam ^a   Cook, C ^a   Hall, A J ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COMPUTER AIDED DESIGN; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; FEMALE; GENERAL PRACTICE; GEOGRAPHY; GROUPS BY AGE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA; SEASONAL VARIATION; TEMPORAL ARTERITIS; TIME; TREND STUDY; UNITED KINGDOM;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; DATABASES, FACTUAL; FAMILY PRACTICE; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; LIKELIHOOD FUNCTIONS; MALE; MIDDLE AGED; POLYMYALGIA RHEUMATICA; SEASONS; TEMPORAL ARTERITIS;

EID: 33744796307     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.046912     Document Type: Article

References (36)

1. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002;347:261-71.
2. Silman AJ. Polymyalgia rheumatica and giant cell arteritis. In: Silman A, Hochberg MC, eds. Epidemiology of the rheumatic diseases. Oxford: Oxford University Press, 2001:188-9.
3. Cantini F, Niccoli L, Storri L, Nannini C, Olivieri I, Padula A, et al. Are polymyalgia rheumatica and giant cell arteritis the same disease? Semin Arthritis Rheum 2004;33:294-301.
4. Cameron A. Temporal arteritis in general practice. BMJ 1959;268:1291-6.
5. Kyle V, Silverman B, Silman A, King H, Oswald N, Reiss B, et al. Polymyalgia rheumatica/giant cell arteritis in a Cambridge general practice. Br Med J (Clin Res Ed) 1985;291:385-7.
6. Walley T, Mantgani A. The UK General Practice Research Database. Lancet 1997;350:1097-9.
7. Office for National Statistics. Key health statistics from general practice 1996. London: Office for National Statistics, 1998, (Series MB6 No.1.).
8. Hollowell J. The General Practice Research Database: quality of morbidity data. Popul Trends, 1997;Spring, 36-40.
9. Lewis JD, Bilker WB, Weinstein R, Strom BL. Measuring incidence rates using GPRD: how soon after registration do incidence rates reach baseline levels? Pharmacoepid Drug Safety 2004;13:S230-1.
10. Kirkwood BR, Sterne JAC. Standardization. Essential medical statistics. 2nd ed. Oxford: Blackwell, 2003:263-71.
11. Gran JT, Myklebust G. The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, south Norway: a prospective study 1987-94. J Rheumatol 1997;24:1739-43.
12. Gonzalez-Gay MA, Garcia-Porrua C, Vazquez-Caruncho M, Dababneh A, Hajeer A, Ollier WE. The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study. J Rheumatol 1999;26:1326-32.
13. Gonzalez-Gay MA, Garcia-Porrua C, Rivas MJ, Rodriguez-Ledo P, Llorca J. Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period. Ann Rheum Dis 2001;60:367-71.
14. Cimmino MA. Genetic and environmental factors in polymyalgia rheumatica. Ann Rheum Dis 1997;56:576-7.
15. Hunder GG. Epidemiology of giant-cell arteritis. Cleve Clin J Med 2002;69(uppl 2):SII79-82.
16. Doran MF, Crowson CS, O'Fallon WM, Hunder GG, Gabriel SE. Trends in the incidence of polymyalgia rheumatica over a 30 year period in Olmsted County, Minnesota, USA. J Rheumatol 2002;29:1694-7.
17. Salvarani C, Crowson CS, O'Fallon WM, Hunder GG, Gabriel SE. Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum 2004;51:264-8.
18. Nordborg C, Johansson H, Petursdottir V, Nordborg E. The epidemiology of biopsy-positive giant cell arteritis: special reference to changes in the age of the population. Rheumatology (Oxford) 2003;42:549-52.
19. Bird HA, Leeb BF, Montecucco CM, Misiuniene N, Nesher G, Pai S, et al. A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumatica. Ann Rheum Dis 2005;64:626-9.
20. Bird HA, Esselinckx W, Dixon AS, Mowat AG, Wood PH. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 1979;38:434-9.
21. Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 1982;97:672-80.
22. Nobunaga M, Yoshioka K, Yasuda M, Shingu M. Clinical studies of polymyalgia rheumatica. A proposal of diagnostic criteria. Jpn J Med 1989;28:452-6.
23. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122-8.
24. Kinmont PD, Mccallum DI. The aetiology, pathology and course of giant-cell arteritis. The possible role of light sensitivity. Br J Dermatol 1965;77:193-202.
25. Cimmino MA, Caporali R, Montecucco CM, Rovida S, Baratelli E, Broggini M. A seasonal pattern in the onset of polymyalgia rheumatica. Ann Rheum Dis 1990;49:521-23.
26. Sonnenblick M, Nesher G, Friedlander Y, Rubinow A. Giant cell arteritis in Jerusalem: a 12-year epidemiological study. Br J Rheumatol 1994;33:938-41.
27. Jonasson F, Cullen JF, Elton RA. Temporal arteritis. A 14-year epidemiological, clinical and prognostic study. Scott Med J 1979;24:111-17.
28. Petursdottir V, Johansson H, Nordborg E, Nordborg C. The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations. Rheumatology (Oxford) 1999;38:1208-12.
29. Raynauld JP, Bloch DA, Fries JF. Seasonal variation in the onset of Wegener's granulomatosis, polyarteritis nodosa and giant cell arteritis. J Rheumatol 1993;20:1524-6.
30. Narvaez J, Clavaguera MT, Nolla-Sole JM, Valverde-Garcia J, Roig-Escofet D. Lack of association between infection and onset of polymyalgia rheumatica. J Rheumatol 2000;27:953-7.
31. Peris P. Polymyalgia rheumatica is not seasonal in pattern and is unrelated to parvovirus b19 infection. J Rheumatol 2003;30:2624-6.
32. Bird H. European diagnostic criteria for polymyalgia rheumatica. Ann Rheum Dis 2001;60(suppl 1):10-11.
33. Jones JG, Hazleman BL. Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis 1981;40:1-5.
34. Healey LA. Long-term follow-up of polymyalgia rheumatica: evidence for synovitis. Semin Arthritis Rheum 1984;13:322-8.
35. Chakravarty K, Elgabani SH, Scott DG, Merry P. A district audit on the management of polymyalgia rheumatica and giant cell arteritis. Br J Rheumatol 1994;33:152-6.
36. Bahlas S, Ramos-Remus C, Davis P. Utilisation and costs of investigations, and accuracy of diagnosis of polymyalgia rheumatica by family physicians. Clin Rheumatol 2000;19:278-80.